Rehearing Denied In Dispute Over Cholesterol Treatment Patents
WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on June 21 denied a petition for rehearing of a recent ruling that confirmed as invalid for lack of enablement two...To view the full article, register now.
Already a subscriber? Click here to view full article